StockRing.com   Home    DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH   
  iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   
 5/23/2013, (NASDAQ:MRK), $47.33 +0.62, +1.33%, "HOLD" Merck & Compan Stock
 




  Enter Stock
  
  
   
On   5/23/2013   StockRing.com recommends to   "HOLD"   MRK   stock at current price of   $47.33.
Today MRK stock opened at $46.43 and was trading in the daily range of $ 728450 per share.
Merck & Compan (NASDAQ:MRK) Market capitalization is $142.9B. MRK average daily volume is N/A.
On last trading session MRK stock traded 21,796,608 shares. Also the Short Ratio for (NASDAQ:MRK) stock is 46.207B.
Last year Merck & Compan(NASDAQ:MRK) before taxes (EBITDA) (ttm) earned $47.34 on revenue of $2.66.
MRK 50-Day Moving Average is $16.365B vs. $47.33 now and 200-Day Moving Average is $46.39 vs. $47.33.
--------------------------------------------------------------------------------------------------------------------
VIX has "HOLD" rating.  Nasdaq has "SUPER BUY" rating.  S&P 500 has "SUPER BUY" rating on   TODAY 
1200 Stocks: Buy 14% 172,  Sell 42% 497,  Hold 44% on   TODAY 
Our Best sector to "Buy" is Health with 23% or 46 stocks to BUY last rated on  TODAY 
Our Worst sector to "Sell" is Finance with 53% or 106 stocks to SELL rated on  TODAY 
--------------------------------------------------------------------------------------------------------------------
MRK Earnings Per Share - EPS (ttm) is 1.96. MRK Stock Price Per Earnings ratio - P/E is 23.83.
Merck & Compan(NASDAQ:MRK)
stock pays a dividend of $ " per share which is a yield of "NYSE"%.
On average analysts predict that One Year Target Estimated price for MRK stock is $44.04.
In the last 52 weeks MRK stock was trading in the range of $37.02 - 48.79.
 
 
BUY  DOW 30+: HPQ  GPC  RTN  SPLS  VFC     ENERGY: COG  HEP  MMP  EEP  EGN     HEALTH: AMGN  MGLN  CNMD  GENT  IMMU 
      FINANCE: CIT  MCY  AXP  ANAT  SIVB     SERVICES: CTL  HD  SRCL  DEG  WCN     TECH: CSGP  WDC  OTEX  PAY  CA 
SELL  DOW 30+: DIS  AEE  ETR  KMB  PM     ENERGY: APA  AREX  DO  MTRX  NS     HEALTH: SNN  STJ  CSU  BAX  CBM 
      FINANCE: ACAS  AWH  BLK  CNS  CYN     SERVICES: AMX  AVB  CCI  DTV  EQR     TECH: CPHD  IPGP  LLTC  QLGC  A 

Our FREE iPhone App gives Buy-Sell-Hold ratings for 1,200 stocks!
 1. Dow 30+ - 200 Stocks   on  TODAY :   Buy   12% or 24    Hold   46% or 92    Sell   42% or 84
 2. Energy - 200 Stocks   on  TODAY :   Buy   19% or 38    Hold   43% or 87    Sell   38% or 75
 3. Health - 200 Stocks   on  TODAY :   Buy   23% or 46    Hold   55% or 110    Sell   22% or 44
 4. Finance - 200 Stocks   on  TODAY :   Buy   9% or 18    Hold   38% or 76    Sell   53% or 106
 5. Services - 200 Stocks   on  TODAY :   Buy   14% or 27    Hold   37% or 75    Sell   49% or 98
 6. Tech - 200 Stocks   on  TODAY :   Buy   10% or 19    Hold   45% or 91    Sell   45% or 90
 
  TOTAL RATING:   Buy   14% or 172    Hold   44% or 531    Sell   42% or 497 

Samples of StockRing Real Time "Buy-Sell-Hold" stock Ratings:



  Enter Stock:  
  
    
    
 
 



Download StockRing Free  Buy-Sell-Hold iPhone
App for 1,200 stocks in Energy Healthcare Finance Services & Tech


DOW 30+

ENERGY

HEALTH

FINANCE

SERVICES

TECH

BUY  DOW 30+: VFC  SYT  SPLS  RTN  NSC     ENERGY: XCO  VTNR  TOT  TLLP  TGS     HEALTH: WX  WST  WCRX  TRIB  TECH 
      FINANCE: WLP  SIVB  MKL  MCY  JPM     SERVICES: WM  WCN  WAG  TLK  SRCL     TECH: WDC  STX  SNPS  PAY  OTEX 
SELL  DOW 30+: XEL  WPZ  WMT  WLK  WAB     ENERGY: YZC  WMB  WLL  WFT  VNR     HEALTH: WOOF  WCG  VRX  VASC  VAR 
      FINANCE: ZION  XLI  XLB  WSH  WDR     SERVICES: WYNN  WMT  VZ  VTR  VOD     TECH: YNDX  WCC  VRSN  VMW  TXN 

 
DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

Our FREE iPhone App gives Buy-Sell-Hold ratings for 1,200 stocks!
 1. Dow 30+ - 200 Stocks   on  TODAY :   Buy   12% or 24    Hold   46% or 92    Sell   42% or 84
 2. Energy - 200 Stocks   on  TODAY :   Buy   19% or 38    Hold   43% or 87    Sell   38% or 75
 3. Health - 200 Stocks   on  TODAY :   Buy   23% or 46    Hold   55% or 110    Sell   22% or 44
 4. Finance - 200 Stocks   on  TODAY :   Buy   9% or 18    Hold   38% or 76    Sell   53% or 106
 5. Services - 200 Stocks   on  TODAY :   Buy   14% or 27    Hold   37% or 75    Sell   49% or 98
 6. Tech - 200 Stocks   on  TODAY :   Buy   10% or 19    Hold   45% or 91    Sell   45% or 90
 
  TOTAL RATING:   Buy   14% or 172    Hold   44% or 531    Sell   42% or 497 
 
DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

Our FREE iPhone App with Buy-Sell-Hold ratings for 1,200 stocks:

  iPhone App Buy-Sell-Hold Ratings for 5-5-2013
           
           
           
           
     
  

 
  Enter Stock:  
  
    
    
 



5/23/2013  Thursday, May 23, 2013 (Irvine, California) Today StockRing.com Recommendation is to "HOLD"for Merck & Compan (NASDAQ:MRK) Stock. MRK stock opening price was $46.43 per share. Current price of NASDAQ:MRK Stock is $47.33 per share and it is $+0.62, (+1.33%) today and it was trading in the daily range of $728450 per share. Current Bid Price for (NASDAQ:MRK) stock is $3.64 and the Ask Price is $47.33. In the last 52 weeks MRK stock was trading in the range of $37.02 - 48.79. 50-Day Moving Average for (NASDAQ:MRK) stock is $16.365B and 200-Day Moving Average is $46.39. On average analysts predict that One Year Target Estimated price for (NASDAQ:MRK) stock is $44.04.

Merck & Compan (NASDAQ:MRK) is rated as a wait on 5/23/2013 10:56:49 AM.

Merck & Compan (NASDAQ:MRK) Market capitalization is $142.9B. (NASDAQ:MRK) stock average daily volume is N/A shares per day. However, on last trading session of 4:00pm, 2012 MRK stock traded 21,796,608 shares. Also The Number of days it would take short sellers on average to repurchase all the borrowed shares or Short Ratio for (NASDAQ:MRK) stock is 46.207B. On previous trading session MRK Stock closed at $46.71 per share.

Last year Merck & Compan (NASDAQ:MRK) before taxes (EBITDA) (ttm) earned $47.34 on total revenue of $2.66. Earnings Per Share - EPS (ttm) for MRK stock is 1.96. Also, (NASDAQ:MRK) Stock Price Per Earnings ratio - P/E is 23.83. Thus, (NASDAQ:MRK) Stock Price/Sales (ttm) ratio is 50.11 and Price/Book (mrq) ratio is 3.05.

(NASDAQ:MRK) Stock pays a dividend of $ " per share which is a yield of "NYSE"%. So at this time (NASDAQ:MRK) Stock maintains Trailing Annual Dividend Rate at 1.90.


StockRing Recommendations for Merck & Compan (NASDAQ:MRK) Stock are updated daily here

http://StockRing.com/sr/Buy-Sell-Hold-Stock-Analysis-Ratings.asp?StockName=MRK

At this time StockRing recommends to buy LONG positions on many stocks from Dow 30+ stocks that currently have a BUY or SUPER BUY rating. If you decide to take a SHORT position and actually sell some stocks sjort right now - please check the section of Dow 30+ stocks that have a SELL or SUPER SELL rating.

If you would like to receive Buy-Sell-Hold ratings for stocks from Energy, Healthcare, Finance, Services & Hi-Tech sectors on your iPhone, then please download Buy-Sell-Hold iPhone App here:


Free Limited or $10 Full Version  Buy-Sell-Hold iPhone App
for 1,200 stocks in Energy, Healthcare, Finance, Services and Tech


DOW 30+

ENERGY

HEALTH

FINANCE

SERVICES

TECH


 
  Enter Stock:  
  
    
    
 

 
DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

NASDAQ:MRK Stock Charts:   1d   5d   3m   6m   1y   2y   5y   Max    Options   More Info

5/23/2013 1 Year Stock market price chart for Merck & Compan (NASDAQ:MRK) Stock on Thursday, May 23, 2013
  
1 Year MRK 1 Year Dow Jones
1 Year Nasdaq 1 Year S&P 500
5/23/2013 5 days Stock market price chart for Merck & Compan (NASDAQ:MRK) Stock on Thursday, May 23, 2013
  
5 Days MRK 5 Days Dow Jones
5 Days Nasdaq 5 Days S&P 500
  

EUROs for $1 DOLLAR: 30 days
     

NASDAQ:MRK Stock Charts:   1d   5d   3m   6m   1y   2y   5y   Max    Options   More Info
 
DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

5/23/2013 Stock market price quote data for Merck & Compan (NASDAQ:MRK) Stock on Thursday, May 23, 2013

Last Trade: 47.33
Trade Time: 4:00pm
Change: +0.62, (+1.33%)
Prev Close: 46.71
Open: 46.43
Bid: 3.64
Ask: 1.70
1y Target Est: $44.04
50-Day Moving Average: 16.365B
200-Day Moving Average:
46.39
Short Ratio: 46.207B
Trailing Annual Dividend Rate: 1.90
Day's Range: 728450
52wk Range: 37.02 - 48.79
Volume: 21,796,608
Avg Vol: N/A
Market Cap: 142.9B
P/E (ttm): 23.83
EPS (ttm): 1.96
Div & Yield: " ("NYSE"%)
Revenue (ttm): 2.66
Earnings before Tax (EBITDA) (ttm): 47.34
Price/Sales (ttm): 50.11
Price/Book (mrq): 3.05
 
DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

  
  
 
DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

MERCK CO INC(NYSE: MRK) Company Information

Merck & Co. Inc.
PO Box 100
One Merck Drive
Whitehouse Station, NJ 08889-0100
United States - Map
Phone: 908-423-1000
Fax: 908-735-1253
Web Site: http://www.merck.com

MERCK CO INC(NYSE: MRK) DETAILS

MERCK CO INC(NYSE: MRK) Index Membership: Dow Jones Composite Dow Industrials S&P 100 S&P 500 S&P 1500 Super Comp
MERCK CO INC(NYSE: MRK) Sector: Healthcare
MERCK CO INC(NYSE: MRK) Industry: Drug Manufacturers - Major
MERCK CO INC(NYSE: MRK) Full Time Employees: 52,700

MERCK CO INC(NYSE: MRK) BUSINESS SUMMARY

Merck & Co., Inc. provides products for human and animal health in the United States and internationally. The company?s Pharmaceutical segment offers human health pharmaceutical products, such as therapeutic and preventive agents. Its products comprise Singulair, a leukotriene receptor antagonist for the treatment of asthma and allergic rhinitis; Cozaar, Hyzaar, Vasotec, and Vaseretic, the hypertension and/or heart failure products; Fosamax and Fosamax Plus D for treating osteoporosis; Januvia and Janumet for type 2 diabetes; Cosopt and Trusopt, the ophthalmological products; Zocor, an atherosclerosis product; Maxalt for acute migraine; Propecia to treat male pattern hair loss; Arcoxia to treat arthritis and pain; Proscar to treat symptomatic benign prostate enlargement; and Emend for the prevention of chemotherapy-induced and post-operative nausea and vomiting. Merck & Co.?s Vaccines segment comprises human health vaccines, such as preventative pediatric, adolescent, and adult vaccines. Its products include Gardasil to prevent cervical cancer, pre-cancerous and low-grade lesions, vulvar and vaginal pre-cancers, and genital warts; Varivax to prevent chickenpox; ProQuad, a pediatric combination vaccine against measles, mumps, rubella, and varicella; M-M-R II, a vaccine against measles, mumps, and rubella; RotaTeq to protect against rotavirus gastroenteritis in children; Zostavax for preventing shingles; Primaxin and Cancidas, anti-bacterial/anti-fungal products; Isentress, Crixivan, and Stocrin, antiretroviral therapies for the treatment of HIV infection; and Invanz for the treatment of infection. Merck & Co. has research, collaboration, or licensing agreements with Neuromed Pharmaceuticals, Ltd.; ARIAD Pharmaceuticals, Inc.; GTX, Inc.; Idera Pharmaceuticals; Japan Tobacco Inc.; Galapagos NV; AstraZeneca plc; Metabasis Therapeutics Inc.; and Addex Pharmaceuticals Ltd. The company was founded in 1891 and is headquartered in Whitehouse Station, New Jersey.

MERCK CO INC(NYSE: MRK) KEY EXECUTIVES

Mr. Richard T. Clark , 63 Exec. Chairman, Chief Exec. Officer and Pres $ 4.03M $ 0

Mr. Peter N. Kellogg , 52 Chief Financial Officer and Exec. VP $ 1.60M $ 0

Mr. Kenneth C. Frazier , 54 Exec. VP and Pres of Global Human Health $ 2.00M $ 0

Dr. Peter Kim Ph.D., 50 Exec. VP and Pres of Merck Research Laboratories $ 1.91M $ 0

Mr. Bruce N. Kuhlik , 52 Exec. Vice president and Gen. Counsel $ 1.25M $ 0


Our FREE iPhone App gives Buy-Sell-Hold ratings for 1,200 stocks!
 1. Dow 30+ - 200 Stocks   on  TODAY :   Buy   12% or 24    Hold   46% or 92    Sell   42% or 84
 2. Energy - 200 Stocks   on  TODAY :   Buy   19% or 38    Hold   43% or 87    Sell   38% or 75
 3. Health - 200 Stocks   on  TODAY :   Buy   23% or 46    Hold   55% or 110    Sell   22% or 44
 4. Finance - 200 Stocks   on  TODAY :   Buy   9% or 18    Hold   38% or 76    Sell   53% or 106
 5. Services - 200 Stocks   on  TODAY :   Buy   14% or 27    Hold   37% or 75    Sell   49% or 98
 6. Tech - 200 Stocks   on  TODAY :   Buy   10% or 19    Hold   45% or 91    Sell   45% or 90
 
  TOTAL RATING:   Buy   14% or 172    Hold   44% or 531    Sell   42% or 497 

5/23/2013 Latest stock market news data for Merck & Compan (NASDAQ:MRK) Stock on Thursday, May 23, 2013

 
DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

Hedge Funds Are Dumping Merck & Co., Inc. (MRK)
Insider Monkey (blog) - 1 hour ago
Merck & Co., Inc. (NYSE:MRK) was in 56 hedge funds' portfolio at the end of March. MRK investors should pay attention to a decrease in hedge fund sentiment of late.
MERCK & CO., INC. : Merck Statement on FDA Advisory Committee Meeting for ...
4-traders (press release) - 21 hours ago
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today provided the following statement after the conclusion of the Peripheral and Central Nervous System Drugs Advisory Committee meeting of the U.S.
FDA panel backs experimental Merck insomnia drug - TheNewsTribune.com
New sleep pill may be unsafe at higher doses, FDA review suggests - NBCNews.com (blog)
The Boeing Company (BA), Merck & Co., Inc. (MRK), Verizon Communications ...
Insider Monkey (blog) - 6 hours ago
Merck & Co., Inc. (NYSE:MRK) also announced today that it would be buying back additional shares. The company plans to spend $5 billion on almost 100 million shares that Goldman Sachs owns.
Medtronic, Inc. (MDT), Merck & Co., Inc. (MRK), AutoZone, Inc. (AZO): Today's ...
Insider Monkey (blog) - May 21, 2013
Medtronic, Inc. (NYSE:MDT) There's hardly any certainty in the market, but even I have to admit it's become almost comical that the Nasdaq Composite has hit a new high (including intraday highs) in 17 straight sessions while the broad-based S&P 500 ...
Merck To Repurchase $5B Shares From Goldman Sachs
ValueWalk - May 22, 2013
Drugmaker Merck & Co., Inc. (NYSE:MRK) today unveiled an accelerated share buyback program worth $5 billion. The country's second largest pharmaceutical company said it has reached a deal to buy 99.5 million of its own shares from Goldman Sachs ...
MERCK & CO., INC. : Merck Announces $5 Billion Accelerated Share Repurchase - 4-traders (press release)
Merck Signs $5B Share Buyback Agreement with Goldman Sachs - Fox Business
Merck & Co., Inc. (MRK), Pfizer Inc. (PFE), AstraZeneca plc (ADR) (AZN) - Pick ...
Insider Monkey (blog) - May 20, 2013
Merck & Co., Inc. (NYSE:MRK) Overweight and have high cholesterol? You may have to pick one to work on at a time, according to data from the lab of John Thyfault, an associate professor of nutrition and exercise physiology at University of Missouri.
Cisco Systems, Inc. (CSCO), Merck & Co., Inc. (MRK), The Coca-Cola Company ...
Insider Monkey (blog) - May 20, 2013
Merck & Co., Inc. (NYSE:MRK) has also dropped, falling 1.4% after the FDA expressed concerns about the side effects of the company's suvorexant insomnia drug.
Merck & Co., Inc. (MRK), Alcoa Inc (AA): Dow (.DJI) Sputters as Rally Runs Out ...
Insider Monkey (blog) - May 21, 2013
Merck & Co., Inc. Turning to the Dow, Merck & Co., Inc. (NYSE:MRK) was the worst performer, falling 1.7% after FDA reviewers questioned dosage levels in a new sleep aid drug.
Merck & Co., Inc. (MRK): What Happened?
Insider Monkey (blog) - May 21, 2013
Merck & Co., Inc. (NYSE:MRK) Federal Reserve officials seem to be having a running internal debate about the efficacy and future of quantitative easing.
Why The Dow Jones Industrial Average Laggard Is An Important Leading Indicator - ETF Daily News
Stock Market News for May 22, 2013 - Market News - NASDAQ
Merck & Co., Inc. (MRK), Illumina, Inc. (ILMN), GlaxoSmithKline plc (ADR) (GSK ...
Insider Monkey (blog) - May 20, 2013
Merck & Co., Inc. (NYSE:MRK) There's good news and bad news for Americans. The good news is that the age-adjusted death rate in the U.S.

 
DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   


Insider Monkey (blog)

Dow Slips, Led Lower by Merck Stock
Motley Fool
That day was today, and the blue chip index's largest decliner was Merck's (NYSE: MRK ) stock. Of course, today's slip isn't really a big deal. But in a market that's become accustomed to all-time highs day in and day out, Monday's minuscule decline ...
Fed Worries, Weak China Data Weighing On Investor SentimentRTT News
Stock Market News for May 22, 2013Zacks.com
Why Dow Jones Laggards Are Important Leading IndicatorsTrefis
Insider Monkey (blog) -Fox Business -Learning and Finance
all 234 news articles »

Philly.com

Merck Enters Share Repurchase Agreement With Goldman Sachs
Motley Fool
As part of an overall stock buyback scheme, Merck (NYSE: MRK ) has launched an accelerated repurchase program to buy shares held by Goldman Sachs (NYSE: GS ) . All told, the pharmaceutical company will purchase $5 billion worth of its stock from the ...
Merck Announces $5 Billion Accelerated Share RepurchaseBusiness Wire (press release)
Merck Unveils $5 Billion Accelerated Share BuybackFox Business
Merck to buy $5B in stock from Goldman Sachs in jump-start for repurchase planFiercePharma
Businessweek -Reuters -Seeking Alpha
all 10 news articles »

Insider Monkey (blog)

Cisco Stock Among Dow's Biggest Losers
Motley Fool
The markets didn't make significant moves but a few stocks did make big moves lower. Merck (NYSE: MRK ) was the biggest loser on the Dow, falling 1.7%. The FDA released some safety concerns about an experimental insomnia drug including daytime ...
Market Minute: Markets Swoon on Threat of Higher Interest RatesDailyFinance
Merck & Co., Inc. (MRK), Alcoa Inc (AA): Dow (.DJI) Sputters as Rally Runs Out ...Insider Monkey (blog)

all 34 news articles »

Merck Stock: Not a Safe Pick for Dividend Investors
Motley Fool
Big pharma isn't the first industry many investors envision when dreaming of the big profits to be made from health care stocks. While blockbuster drugs can propel the top big pharma companies to massive profits, these broad behemoths can't match the ...


Merck Stock Down, Could Have Been Worse
Motley Fool
Merck's (NYSE: MRK ) stock was down almost 3% on Wednesday after the company released first quarter earnings. Revenue dropped, but that was to be expected, with asthma-drug Singulair seeing generic competition. Every investor knew it was going to ...
Merck Can Still Make It WorkBarron's
Merck Stock Drops After Q1 Sales Miss, Guidance CutInvestor's Business Daily
Merck Cuts Profit Forecast as Buyback Boosted $15 BillionBloomberg
The Utah People's Post -EON: Enhanced Online News (press release) -Fox Business
all 54 news articles »

ValueWalk

How Will Merck Stock Do After Earnings?
Motley Fool
Merck (NYSE: MRK ) stock could move up or down this week after the pharmaceutical company reports earnings on Wednesday. Here's a look at what to expect and the biggest divers of the price for Merck stock. Currency hurts. For drugmakers that report in ...
Merck, Pfizer Team Up To Develop Diabetes DrugValueWalk
Merck - Pfizer in Diabetes DealZacks.com

all 37 news articles »

Merck Becomes #21 Most Shorted Dow Stock, Replacing Travelers
Forbes
The most recent short interest data has been released by the NASDAQ for the 04/30/2013 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Dow Jones Industrial Average by ...

and more »

MiamiHerald.com

Merck Stock Is Holding Back the Dow
Motley Fool
The Dow Jones Industrial Average (DJINDICES: ^DJI ) is down following some mixed economic releases and a poor earnings release from Merck (NYSE: MRK ) . As of 1:10 p.m. EDT the Dow is down 91 points, or 0.61%, to 14,749. The S&P 500 (SNPINDEX: ...
Stocks Open Lower After Weak ADP ReportCNBC.com
MARKET SNAPSHOT: US Stocks Drop As Companies Miss On RevenueFox Business
Wall Street drops on data, earnings; Facebook up lateReuters
Wall Street Journal -Lloyd's List -Capital.gr (press release)
all 716 news articles »

1 Potential Roadblock for the Merck Stock Run-up
Motley Fool
While there are several potential roadblocks for sustained stock success, probably the most likely to make a difference in the coming months is a failure in Merck's pipeline. Another experience like Merck had with Tredaptive could easily stop the stock ...

and more »

Early Movers: TGT, LOW, MRK, SPLS & More
CNBC.com (blog)
MerckMerck announced a $5 billion accelerated share repurchase program. The drug maker will buy back nearly 100 million shares from Goldman Sachs at current market prices. Sony —Sony has cut sales targets for digital cameras, smartphones, and ...

 
DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   



5/23/2013 News from StockRing Blog about Merck & Compan (NASDAQ:MRK) Stock on Thursday, May 23, 2013



Copyright © 2012 StockRing.com. All rights reserved.
Subscriber Agreement   Privacy Agreement   Stocks   MutualFunds

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither StockRing.com nor its partners shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the StockRing site, a user agrees not to redistribute the information found therein.